Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice

Clinical Science

Volumn 122, Issue 11, 2012, Pages 545-553

  Maina, Virginia ^a,b   Sutti, Salvatore ^a   Locatelli, Irene ^a   Vidali, Matteo ^a   Mombello, Cristina ^a   Bozzola, Cristina ^a   Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Cytokine; Kuppfer cell; Liver inflammation; Liver injury; Non alcoholic fatty liver disease; Strain difference

Indexed keywords

CHOLINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 4; LECTIN; MACROPHAGE GALACTOSE TYPE C TYPE LECTIN 1; MESSENGER RNA; METHIONINE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEEDING; GENE EXPRESSION; HISTOPATHOLOGY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FATTY LIVER; IMMUNOLOGY; LIVER; PATHOLOGY; TH1 TH2 BALANCE;

ANIMALS; DISEASE SUSCEPTIBILITY; FATTY LIVER; LIVER; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH1-TH2 BALANCE;

EID: 84860243402     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110366     Document Type: Article

References (38)

1. Reid, A. E. (2001) Nonalcoholic steatohepatitis. Gastroentorology 121, 711-723.
2. Sanyal, A. J. (2005) Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 46-53.
3. Cortez-Pinto, H., Caneiro de Moura, M. and Day, C. P. (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44, 197-208.
4. Marra, F., Gastaldelli, A., Svegliati-Baroni, G., Tell, G. and Tiribelli, C. (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14, 72-81.
5. Tilg, H. and Moschen, A. R. (2010) Evolution of inflammation in non-alcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846.
6. Crespo, J., Cayon, A., Fernandez-Gil, P., Hernandez-Guera, M., Mayorga, M., Dominiguez-Diez, A., Fernández-Escalante, J. C. and Pons-Romero, F. (2001) Gene expression of tumor necrosis factor alpha and TNF-receptors p55 and p75 in nonalcoholic steatohepatitis patients. Hepatology 34, 1158-1163.
7. Wirtz, S. and Neurath, M. F. (2007) Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59, 1073-1083.
8. De Maio, A., Torres, M. B. and Reeves, R. H. (2005) Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 23, 11-17.
9. Allayee, H., Andalibi, A. and Mehrabian, M. (2006) Using inbred mouse strains to identify genes for complex diseases. Front. Biosci. 11, 1216-1226.
10. Rangnekar, A. S., Lammert, F., Igolnikov, A. and Green, R. M. (2006) Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis. Liver Int. 26, 1000-1005.
11. Yamazaki, Y., Kakizaki, S., Takizawa, D., Ichikawa, T., Sato, K., Takagi, H. and Mori, M. (2008) Interstrain differences in susceptibility to non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 23, 276-282.
12. Syn, W. K., Yang, L., Chiang, D. J., Qian, Y., Jung, Y., Karaca, G., Choi, S. S., Witek, R. P., Omenetti, A., Pereira, T. A. and Diehl, A. M. (2009) Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. Liver Int. 29, 1262-1272.
13. Hill-Baskin, A. E., Markiewski, M. M., Buchner, D. A., Shao, H., DeSantis, D., Hsiao, G., Subramaniam, S., Berger, N. A., Croniger, C., Lambris, J. D. and Nadeau, J. H. (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum. Mol. Gen. 18, 2975-2988.
14. Pogribny, I. P., Tryndyak, V. P., Bagnyukova, T. V., Melnyk, S., Montgomery, B., Ross, S. A., Latendresse, J. R., Rusyn, I. and Beland, F. A. (2009) Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J. Hepatol. 51, 176-186.
15. Kaminski, D. and Randall, T. D. (2010) Adaptive immunity and adipose tissue biology. Trends Immunol. 31, 384-390.
16. Olefsky, J. M. and Glass, C. K. (2010) Macrophages, inflammation and insulin resistance. Annu. Rev. Physiol. 72, 219-246.
17. Stein, O., Thiery, J. and Stein, Y. (2002) Is there a genetic basis for resistance to atherosclerosis? Atherosclerosis 160, 1-10.
18. Schulte, S., Sukhova, G. K. and Libby, P. (2008) Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am. J. Pathol. 172, 1500-1508.
19. Wynn, T. A. (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583-594.
20. Mill, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. and Hill, A. M. (2000) M1/M2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
21. Mosser, D. M and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
22. Larter, C. Z. and Yeh, M. M. (2008) Animal model of NASH: getting both pathology and metabolic contest right. J. Gastroenterol. Hepatol. 23, 1635-1648.
23. Froh, M., Konno, A. and Thurman, R. G. (2002) Isolation of Kupffer cells. Curr. Protoc. Toxicol. 14, 1-12.
24. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y. C., Torbenson, M. S., Unalp-Arida, A. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
25. Lafdil, F., Miller, A. M., Ki, S. H. and Gao, B. (2010) Th17 cells and their associated cytokines in liver diseases. Cell. Mol. Immunol. 7, 250-254.
26. Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V. et al. (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49, 646-657.
27. Bieghs, V., Rensen, P. C., Hofker, M. H. and Shiri-Sverdlov, R. (2011) NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis 220, 287-293.
28. Huber, S. A., Sakkinen, P., David, C., Newell, M. K. and Tracy, R. P. (2001) T-helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103, 2610-2616.
29. Schulte, S., Sukhova, G. K. and Libby, P. (2008) Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am. J. Pathol. 172, 1500-1508.
30. Hansson, G. K. and Libby, P. (2006) The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508-519.
31. Li, Z., Soloski, M. J. and Diehl, A. M. (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42, 880-885.
32. Kremer, M., Hines, I. N., Milton, R. J. and Wheeler, M. D. (2006) Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 44, 216-227.
33. Mantovani, A., Garlanda, C. and Locati, M. (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Artheriosler. Thromb. Vasc. Biol. 29, 1419-1423.
34. Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M. C., Iannelli, A., Gugenheim, J., Barr, J., Mato, J. M., Le Marchand-Brustel, Y. et al. (2010) Hepatic expression pattern of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS ONE 5, e13577.
35. Mencin, A., Kluwe, J. and Schwabe, R. F. (2009) Toll-like receptors as targets in chronic liver diseases. Gut 58, 704-720.
36. Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A. and Seki, E. (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139, 323-334.
37. Miller, Y. I., Choi, S. H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X. et al. (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235-248.
38. Rensen, S. S., Slaats, Y., Driessen, A., Peutz-Kootstra, C. J., Nijhuis, J., Steffensen, R., Greve, J.W. and Buurman,W. A. (2009) Activation of complement system in human non-alcoholic fatty liver disease. Hepatology 50, 1809-1817